Loading...
Keywords
Last Name
Institution
 Back to Details

Connection

Rangaraj Selvarangan to Antibodies, Viral

This is a "connection" page, showing publications Rangaraj Selvarangan has written about Antibodies, Viral.

 
Connection Strength
  
 
 
1.993
  
  1. Harrison CJ, Weldon WC, Pahud BA, Jackson MA, Oberste MS, Selvarangan R. Neutralizing Antibody against Enterovirus D68 in Children and Adults before 2014 Outbreak, Kansas City, Missouri, USA1. Emerg Infect Dis. 2019 03; 25(3):585-588.
    View in: PubMed
    Score: 0.642
  2. Romero JR, Selvarangan R. The human Parechoviruses: an overview. Adv Pediatr. 2011; 58(1):65-85.
    View in: PubMed
    Score: 0.365
  3. Adhikari B, Hassan F, Harrison CJ, Dien Bard J, Dunn J, Kehl S, Selvarangan R. A multi-center study to determine genetic variations in the fusion gene of respiratory syncytial virus (RSV) from children <2 years of age in the U.S. J Clin Virol. 2022 09; 154:105223.
    View in: PubMed
    Score: 0.202
  4. Fraley E, LeMaster C, Banerjee D, Khanal S, Selvarangan R, Bradley T. Cross-reactive antibody immunity against SARS-CoV-2 in children and adults. Cell Mol Immunol. 2021 07; 18(7):1826-1828.
    View in: PubMed
    Score: 0.188
  5. Bradley T, Grundberg E, Selvarangan R, LeMaster C, Fraley E, Banerjee D, Belden B, Louiselle D, Nolte N, Biswell R, Pastinen T, Myers A, Schuster J. Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine. N Engl J Med. 2021 05 20; 384(20):1959-1961.
    View in: PubMed
    Score: 0.185
  6. Karelehto E, Brouwer L, Benschop K, Kok J, Basile K, McMullan B, Rawlinson W, Druce J, Nicholson S, Selvarangan R, Harrison C, Lankachandra K, van Eijk H, Koen G, de Jong M, Pajkrt D, Wolthers KC. Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States. Emerg Infect Dis. 2019 01; 25(1):148-152.
    View in: PubMed
    Score: 0.159
  7. Morgans HA, Bradley T, Flebbe-Rehwaldt L, Selvarangan R, Bagherian A, Barnes AP, Bass J, Cooper AM, Fischer R, Kleiboeker S, Lee BR, LeMaster C, Markus K, Morrison S, Myers A, Myers D, Payne E, Schuster JE, Standley S, Wieser A, Warady B. Humoral and cellular response to the COVID-19 vaccine in immunocompromised children. Pediatr Res. 2023 07; 94(1):200-205.
    View in: PubMed
    Score: 0.052
  8. LeMaster C, Geanes ES, Fraley ER, Selvarangan R, Bradley T. Vaccination After SARS-CoV-2 Infection Increased Antibody Avidity Against the Omicron Variant Compared to Vaccination Alone. J Infect Dis. 2022 11 11; 226(10):1712-1716.
    View in: PubMed
    Score: 0.052
  9. Fraley E, LeMaster C, Khanal S, Banerjee D, Pastinen T, Grundberg E, Selvarangan R, Bradley T. The Impact of Prior Infection and Age on Antibody Persistence After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine. Clin Infect Dis. 2022 08 24; 75(1):e902-e904.
    View in: PubMed
    Score: 0.051
  10. Geanes ES, LeMaster C, Fraley ER, Khanal S, McLennan R, Grundberg E, Selvarangan R, Bradley T. Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination. Sci Rep. 2022 04 20; 12(1):6496.
    View in: PubMed
    Score: 0.050
  11. Fraley E, LeMaster C, Geanes E, Banerjee D, Khanal S, Grundberg E, Selvarangan R, Bradley T. Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals. BMC Med. 2021 07 26; 19(1):169.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.